Ireland· IE-PA-PA1077/006/001
Eumovate Cream 0.05% w/w
A clobetasone product containing clobetasone butyrate, registered in Ireland by GlaxoSmithKline (Ireland) Limited. The same ATC class is registered in 7 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Clobetasone is registered in 7 of 19 countries.
Countries holding a registration under ATC D07AB01 (clobetasone), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 3 of them publish a price we can compare per daily dose
Clobetasone · ATC D07AB01
7 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Ireland
- Japan
- Switzerlandprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- CLOBETASONE BUTYRATE
- Manufacturer
- GlaxoSmithKline (Ireland) Limited
- Country
- Ireland (IE)
- ATC code
- D07AB01
- ATC class
- Clobetasone
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1077/006/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Clobetasone in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCloptisonMerck Sharp & Dohme B.V.
- BelgiumEumovate 0.05 %GlaxoSmithKline Pharmaceuticals
- SwedenEmovat 0,05 % KrämGlaxoSmithKline AB
- CanadaSPECTRO ECZEMACARE MEDICATED CREAMHALEON CANADA ULC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Clobavate, Eumovate
- Italy · Clobet, Eumovate
- Sweden · Emovat
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8e24fa93-7932-4e20-936e-e5971da607ff GET /v1/drugs/8e24fa93-7932-4e20-936e-e5971da607ff?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Cream",
"routes": [
"Topical"
],
"source": "hpra",
"atc_all": [
"D07AB",
"D07AB01"
],
"strength": null,
"pa_number": "PA1077/006/001",
"substances": [
"CLOBETASONE BUTYRATE"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "03/06/1976",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about clobetasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.